T. Rowe Price files 13G/A on Corpay: 3,828,712 shares (5.4%)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed Amendment No. 4 to a Schedule 13G reporting beneficial ownership of 3,828,712 shares of Corpay Inc. (CPAY) common stock, representing 5.4% of the class as of 09/30/2025.
The filer reports sole voting power over 3,686,476 shares and sole dispositive power over 3,828,649 shares, with no shared voting or dispositive power. T. Rowe Price Associates is classified as an investment adviser and certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Corpay.
Positive
- None.
Negative
- None.
FAQ
What stake in Corpay (CPAY) did T. Rowe Price report?
T. Rowe Price Associates reported 5.4% beneficial ownership of Corpay common stock.
What voting and dispositive powers were disclosed?
They have sole voting power over 3,686,476 shares and sole dispositive power over 3,828,649 shares; no shared power was reported.
What is the date tied to this ownership report for CPAY?
The Date of Event is 09/30/2025.
What type of filer is T. Rowe Price in this 13G/A?
It is classified as an investment adviser (IA).
Did T. Rowe Price indicate any intent to influence control of Corpay?
No. They certified the holdings are in the ordinary course and not for changing or influencing control.